Trump's generic drug tariffs: What they could mean for medicine prices, manufacturers and supply

Trump's generic drug tariff plan raises questions over prices, U.S. manufacturing and which drugmakers stand to gain or lose as details remain unclear.
Hosted on MSN

Trump's 100% tariffs on branded drugs: Indian generics spared but pose risks for pharma sector – Explained

US President Donald Trump's announcement of a 100% tariff on imported "branded and patented pharmaceutical products" has rattled the global pharma industry, though Indian generic drug makers are ...